{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:35:27Z","timestamp":1791920127563,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008783","name":"National Research Council of Science & Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008783","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South Korean government"},{"name":"MSIP","award":["CRC-15-04-KIST"],"award-info":[{"award-number":["CRC-15-04-KIST"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2018M3A9C8016849"],"award-info":[{"award-number":["NRF-2018M3A9C8016849"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejmech.2020.113103","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T02:37:49Z","timestamp":1608863869000},"page":"113103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"212","author":[{"given":"Ji Won","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seok","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah Hwejin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7753-214X","authenticated-orcid":false,"given":"Ki Duk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.113103_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5604\/12321966.1232774","article-title":"Motor assessment in Parkinson\u2019s disease","volume":"24","author":"Opara","year":"2017","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.ejmech.2020.113103_bib2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/brain\/awx064","article-title":"New hope for devastating neurodegenerative disease","volume":"140","author":"Stayte","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2020.113103_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2020.113103_bib4","doi-asserted-by":"crossref","first-page":"112385","DOI":"10.1016\/j.ejmech.2020.112385","article-title":"Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson\u2019s disease via the activation of Nrf2\/keap1 pathway","volume":"199","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejmech.2017.09.068","article-title":"Recent advances in discovery and development of natural products as source for anti-Parkinson\u2019s disease lead compounds","volume":"141","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib6","doi-asserted-by":"crossref","first-page":"S497","DOI":"10.1002\/mds.22028","article-title":"The history of dopamine and levodopa in the treatment of Parkinson\u2019s disease","volume":"23","author":"Fahn","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2020.113103_bib7","first-page":"1433","article-title":"Parkinson\u2019s disease: an update on pathogenesis and treatment","volume":"260","author":"Foltynie","year":"2013","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ejmech.2020.113103_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2020.113103_bib9","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s40265-019-01201-1","article-title":"Levodopa\/carbidopa enteral suspension: a review in advanced Parkinson\u2019s disease","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.113103_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopha.2015.07.025","article-title":"Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight","volume":"74","author":"Bhat","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2020.113103_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2016.07.012","article-title":"Curcumin alleviates oxidative stress and mitochondrial dysfunction in astrocytes","volume":"333","author":"Daverey","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2020.113103_bib12","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer\u2019s disease","volume":"16","author":"Agostinho","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2020.113103_bib13","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.3390\/ijms19123824","article-title":"The role of NADPH oxidases and oxidative stress in neurodegenerative disorders","volume":"19","author":"Tarafdar","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2020.113103_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2020.113103_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2020.113103_bib16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejmech.2017.11.048","article-title":"Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin","volume":"143","author":"Deck","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib17","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1021\/jm400224q","article-title":"Keap calm, and carry on covalently","volume":"56","author":"Wilson","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib18","doi-asserted-by":"crossref","first-page":"112734","DOI":"10.1016\/j.ejmech.2020.112734","article-title":"Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions","volume":"207","author":"Lu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib19","first-page":"297","article-title":"Antioxidant response elements: discovery, classes, regulation and potential applications, redox","volume":"17","author":"Raghunath","year":"2018","journal-title":"Biol."},{"key":"10.1016\/j.ejmech.2020.113103_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cvr\/cvp107","article-title":"Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection","volume":"83","author":"Dreger","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2020.113103_bib21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fphar.2017.00868","article-title":"Pelargonidin modulates Keap1\/Nrf2 pathway gene expression and ameliorates citrinin-induced oxidative stress in HepG2 cells","volume":"8","author":"Sharath Babu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.113103_bib22","doi-asserted-by":"crossref","first-page":"101059","DOI":"10.1016\/j.redox.2018.11.017","article-title":"NRF2 and NF-\u049bB interplay in cerebrovascular and neurodegenerative disorders: molecular mechanisms and possible therapeutic approaches","volume":"21","author":"Sivandzade","year":"2019","journal-title":"Redox. Biol."},{"key":"10.1016\/j.ejmech.2020.113103_bib23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1089\/ars.2012.5116","article-title":"The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice","volume":"20","author":"Mo","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2020.113103_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents","volume":"32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2020.113103_bib25","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.3390\/molecules200915989","article-title":"Antioxidant and anti-inflammatory activities of a natural compound, shizukahenriol, through Nrf2 activation","volume":"20","author":"Park","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.113103_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/antiox9060521","article-title":"The integrative role of sulforaphane in preventing inflammation, oxidative stress and fatigue: a review of a potential protective phytochemical","volume":"9","author":"Ruhee","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2020.113103_bib27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41416-020-1025-1","article-title":"Broccoli extract increases drug-mediated cytotoxicity towards cancer stem cells of head and neck squamous cell carcinoma","volume":"123","author":"Elkashty","year":"2020","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2020.113103_bib28","doi-asserted-by":"crossref","first-page":"3549274","DOI":"10.1155\/2019\/3549274","article-title":"Sulforaphane-enriched broccoli sprouts pretreated by pulsed electric fields reduces neuroinflammation and ameliorates scopolamine-induced amnesia in mouse brain through its antioxidant ability via Nrf2-HO-1 activation","volume":"2019","author":"Subedi","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2020.113103_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/jpet.106.110866","article-title":"Protective effect of sulforaphane against dopaminergic cell death","volume":"321","author":"Han","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2020.113103_bib30","doi-asserted-by":"crossref","first-page":"53502","DOI":"10.18632\/oncotarget.10609","article-title":"Chemoprevention of oxidative stress-associated oral carcinogenesis by sulforaphane depends on NRF2 and the isothiocyanate moiety","volume":"7","author":"Lan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2020.113103_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fimmu.2018.00036","volume":"9","author":"Eren","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2020.113103_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson\u2019s disease","volume":"25","author":"Lastres-Becker","year":"2016","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2020.113103_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120254","article-title":"Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in\u00a0vitro","volume":"10","author":"Brennan","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2020.113103_bib34","first-page":"2075","article-title":"Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties","volume":"8","author":"Wang","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2020.113103_bib35","first-page":"3163","article-title":"Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice","volume":"9","author":"Wang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2020.113103_bib36","doi-asserted-by":"crossref","first-page":"28446","DOI":"10.1074\/jbc.M115.678136","article-title":"Characterization of RA839, a Noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling","volume":"290","author":"Winkel","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib37","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/molecules23071803","article-title":"The keap1\/Nrf2-ARE pathway as a pharmacological target for chalcones","volume":"23","author":"de Freitas Silva","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.113103_bib38","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1021\/jm2002348","article-title":"Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells","volume":"54","author":"Kumar","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib39","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1016\/j.bmc.2015.07.056","article-title":"Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in\u00a0vivo efficacy","volume":"23","author":"Lounsbury","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib40","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/jm401788m","article-title":"Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson\u2019s disease therapy","volume":"57","author":"Woo","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib41","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/bph.12973","article-title":"A\u00a0novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson\u2019s disease animal model","volume":"172","author":"Lee","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.113103_bib42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1021\/acs.jmedchem.8b01527","article-title":"Optimization of vinyl sulfone derivatives as potent nuclear factor erythroid 2-related factor 2 (Nrf2) activators for Parkinson\u2019s disease therapy","volume":"62","author":"Choi","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2019.03.063","article-title":"Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: a critical review","volume":"173","author":"Fang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib44","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1021\/acsmedchemlett.8b00300","article-title":"Exploring halogen bonds in 5-hydroxytryptamine 2B receptor\u2013ligand interactions","volume":"9","author":"Zhou","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.113103_bib45","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejmech.2014.12.034","article-title":"N-bridged 5,6-bicyclic pyridines: recent applications in central nervous system disorders","volume":"97","author":"Delgado","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib46","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals","volume":"57","author":"Vitaku","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib47","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1021\/acs.jmedchem.6b01807","article-title":"The necessary nitrogen atom: a versatile high-impact design element for multiparameter pptimization","volume":"60","author":"Pennington","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib48","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/acsmedchemlett.9b00163","article-title":"Antioxidant, anti-inflammatory, and neuroprotective effects of novel vinyl sulfonate compounds as Nrf2 activator","volume":"10","author":"Choi","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.113103_bib49","doi-asserted-by":"crossref","first-page":"111777","DOI":"10.1016\/j.ejmech.2019.111777","article-title":"A\u00a0novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model","volume":"185","author":"Kim","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113103_bib50","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2020.113103_bib51","doi-asserted-by":"crossref","first-page":"107989","DOI":"10.1016\/j.neuropharm.2020.107989","article-title":"Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson\u2019s disease animal model","volume":"167","author":"Kim","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2020.113103_bib52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease. Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420310758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420310758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:18:40Z","timestamp":1759328320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420310758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":52,"alternative-id":["S0223523420310758"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.113103","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.113103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113103"}}